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Abstract
The mechanisms regulating T helper 9 (TH9) cells and TH9-mediated diseases remain poorly
defined. Here, we demonstrate that the receptor OX40 (Tnfrsf4) is a powerful inducer of TH9 cells
in vitro and TH9-dependent airway inflammation in vivo. Under TGF-β based polarizing
conditions, OX40 ligation eliminated production of induced regulatory T cells and TH17 cells, and
divertedCD4+Foxp3− T cells to a TH9 phenotype. Mechanistically, OX40 activated the ubiquitin
ligase TRAF6, which triggered the induction of NF-kB-inducing kinase (NIK) in CD4+ T cells
and the non-canonical NF-kB pathway which subsequently lead toTH9 generation. Thus, our study
identifies a previously unknown mechanism of TH9 induction and may have important clinical
implications in allergic inflammation.
Following T cell receptor triggering the fate of the T cells is controlled, to a large extent, by
signals from T cell costimulatory molecules and cytokines 1,2. In the case of naive CD4+ T
cells, the cytokine milieu in which the cells are activated directsCD4+ T cells to further
differentiate into functionally different subsets i.e., TH1, TH2, TH9, TH17, induced
regulatory cells (iTregs) or T follicular helper (Tfh) cells, which in turn mediate different
types of T cell immunity or immune-mediated diseases 3. For example, transforming growth
factor-β (TGF-β)converts conventional CD4+ T cells to immunosuppressive iTregs by
turning on the expression of Foxp3, while TGF-β in combination with the inflammatory
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cytokinesIL-1, IL-6 or TNF induces the transcription factors RORγt, RORα, and c-Rel that
program the induction of TH17 cells 4. More recently, several studies suggest that together
with IL-4 promote IL-9-producing ‘TH9 cells’ through induction of the transcription factors
PU.1 and IRF4 5,6, although the exact nature of this response and the precise identity of TH9
cells remain somewhat contested. Additionally, activation of CD4+ T cells in an IL-12-rich
environment (without TGF-β) stimulates T-bet expression, which programs the induction of
TH1 cells, whereas an IL-4-rich environment supports TH2 cells via the induction of
Gata3 7. This is of fundamental importance in immunology as individual subsets are often
tailored to respond to specific pathogens. Thus, by inducing specific transcription factors,
cytokines are critical in directing the differentiation of CD4+ T cell subsets.
OX40 (also known as a Tumor necrosis factor receptor super family 4, Tnfrsf4) is a T cell
costimulatory molecule in the TNFR superfamily and traditionally signals through the NF-
kB pathway 8. OX40 is rapidly induced upon T cell activation, most prominently on
activated CD4+ T cells, and OX40 costimulation exerts a broad impact on the overall T cell
immunity 9. In physiological immune responses, OX40 delivers a potent costimulatory
signal to activated CD4+ T cells, supporting their survival and proliferation 9. OX40 also
inhibits Foxp3+ Tregs 10,11, which may indirectly boost T effector cells by relieving them
from Treg-mediated suppression. Furthermore, OX40 directly drives either a TH1 response
or a TH2 response in various models, pointing to a key role for OX40 in the control of the
TH cell differentiation process 12,13. OX40 is also involved in the development of CD4+
memory T cells, possibly by sustaining the expression of the survival factor Bcl-2 14, and in
some models it is indispensible in the memory recall responses 15. However, OX40 can also
contribute significantly to immune pathology in a variety of animal models. For example,
over-expression of OX40 ligand (OX40L, also known as Tnfsf4) as a transgene in B6 mice
induces spontaneous and systemic autoimmune diseases, characterized by heightened
production of autoantibodies, severe inflammation in the gut, and extensive interstitial
pneumonia in the lungs 16. Also, OX40 costimulation has been implicated in the
pathogenesis of autoimmune colitis, experimental autoimmune encephalitis, arthritis,
asthma, and transplant rejection 17. Such a diversity of responses suggests that OX40 mostly
likely employs a variety of mechanisms to control immunity or immune pathology.
Considering the broad effects of OX40 on CD4+ T cell responses, it remains to be defined
how OX40 intersects with cytokine signals in fine-tuning the differentiation of various TH
subsets, and the molecular pathways involved, and whether OX40 favors a specific subset or
broadly affects all TH subsets. In the present study, we addressed this question by assessing
the induction of various CD4+ T cell subsets under TGF-based polarizing conditions. We
found that OX40 is highly selective and potent in the induction of TH9 cells and operates via
activation of the non-canonical NF-kB pathway.
RESULTS
OX40 favors the induction of TH9 cells in vitro
TGF-β, when combined withIL-2, IL-6, orIL-4, convertsCD4+ T conventional cells (Tconv)
to iTregs, TH17 cells, and TH9 cells, respectively 4,18. To determine whether OX40 has any
role in this process, we flow sorted naïve CD4+ Tconv (CD62L+CD44−Foxp3−) from wild
type (WT) Foxp3gfp reporter mice, activated them in vitro under iTreg (TGF-β + IL-2),
TH17 (TGF-β + IL-6), or TH9 (TGF-β + IL-4) polarizing conditions, and examined the
induction of Foxp3, IL-17A, and IL-9 (the signature molecules for iTregs, TH17, TH9 cells
respectively). To deliver OX40 signals to CD4+ Tconv in the culture, we used either
OX40Ltransgenic (OX40Ltg) antigen presenting cells (APCs) or alternatively an agonist
anti-OX40 mAb (OX86) to specifically engage OX40 on activated T cells 10,19. (10ng/ml)
readily converted CD4+ Tconv to Foxp3+ iTregs upon activation with anti-CD3+ syngeneic
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APCs, and ~80% of CD4+ Tconv became Foxp3+ cells 3 days later (Fig. 1a). However, such
iTreg induction was strongly inhibited when CD4+ Tconv were activated with anti-CD3+
OX40Ltg APCs. Similar inhibition of iTregs by OX40 was observed in an antigen-specific
setting in which OT-II cells were activated with the cognate ovalbumin (OVA) antigen
presented by either WTAPCs or OX40Ltg APCs (Fig. 1a). Conversion of CD4+ Tconv to
TH17 cells by was also inhibited by OX40 ligation. As compared to the controls, TGF-β
(3ng/ml) and IL-6 (10ng/ml) converted ~35% of the CD4+ Tconv to IL-17-producing cells 3
days after activation with anti-CD3+ WTAPCs, but OX40 ligation prevented the induction
of IL-17-producing cells under identical TH17 polarizing conditions (Fig. 1b). We
performed Therefore, OX40 can effectively shut down the reciprocal induction of both
iTregs and TH17 cells.
We further examined whether OX40 also impacts TH9 induction by TGF-β and IL-4, and
found that OX40 has a diametrically opposite effect on the induction of TH9 cells. TGF-β
(3ng/ml) plus IL-4 (10ng/ml) converted ~7% of CD4+ Tconv to TH9 cells under conditions
of anti-CD3plus WTAPC stimulation 3 days after the culture, which is within the published
range of most studies 5,6,20 (Fig. 1c). Culturing CD4+ Tconv with anti-CD3+ OX40Ltg
APCs drastically enhanced the induction of TH9 cells, and as much as 50% of the CD4+
Tconv became IL-9 producing cells. Additionally, instead of using OX40Ltg APCs, we used
anti-CD3+ WTAPCs to activate CD4+ Tconv and included the agonist anti-OX40 mAb
(OX86) to engage OX40 signaling. OX86 also markedly enhanced the induction of TH9
cells (Fig. 1d). The specificity of OX40 in TH9 induction was established by activating
WTB6 and Ox40 knockout (KO) CD4+ Tconv under TH9 polarizing conditions, and
induction of TH9 cells from Ox40 KO T cells remained similar regardless of activation with
anti-CD3+ WTAPCs or anti-CD3+ OX40Ltg APCs (~5%), whereas WTCD4+ T cells were
readily converted to TH9 cells by TGF-β + IL-4 upon anti-CD3+ OX40Ltg APC activation
(~50%)(Fig. 1e). Furthermore, the induction of TH9 cells by OX40 is even more profound in
an antigen-specific setting in which OT-II cells were activated with the cognate OVA
antigen under TH9 polarizing conditions. Compared to the controls, ~80% of the OT-II cells
were converted to TH9 cells by in the presence of OX40 ligation (Fig. 2a), which contrasts
sharply to OT-II cells polarized without OX40 ligation (~9%). It should be noted that TH9
cells induced under conditions of OX40 ligation did not express other cytokines, as
demonstrated by co-staining with IL-4, IL-5, IL-10, IL-13, IFN-γ, or IL-17 (Fig. 2b). In
addition, quantitative Real-Time PCR and ELISA showed marked expression of IL-9
message and IL-9 protein by CD4+ Tconv polarized under TH9 conditions in the presence of
OX40 ligation (Fig. 2c and Fig. 2d).
We repeated the TH9 induction experiments up to 10 times with consistent results. We also
titrated the cytokines used in the cultures (0.5 to 3ng/ml for TGF-β and 10 to 30ng/ml for
IL-4) as well as varied the time points (3 to 5 days of culture), OX40 consistently favored
the polarization of TH9 cells (data not shown). Taken together, these experiments
demonstrate the potency of OX40 costimulation in selective induction of TH9 cells.
PU.1 is dispensable for TH9induction by OX40
Recent studies in other settings indentified the transcription factor PU.1 (also known as
Sfp1) as a key transcription factor for the induction of TH9 cells 6. The potency of OX40 in
TH9 induction led us to examine whether Sfp1 is also involved in OX40-mediated induction
of TH9 cells. To this end, we bred Sfp1 floxed mice with Cd4-cre mice to specifically delete
Sfp1 in CD4+ T cells. Flow sorted CD4+ Tconv from Sfp1f/fCd4cre mice were stimulated
with anti-CD3 plus either wt B6 or OX40Ltg APCs under TH9 polarizing conditions, and
examined the induction of IL-9 producing cells by flow cytometry. Wt and Sfp1deleted
CD4+ T cells expressed comparable levels of OX40 on the cell surface following activation
(Fig. 3a), and both proliferation and survival were also similar between such two
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populations upon activation with anti-CD3+ wtAPCs (Fig. 3b). Thus, Sfp1 deletion in CD4+
T cells does not alter OX40 expression and cellular activation. When wt and Sfp1 deleted
CD4+ Tconv were subjected to the same TH9 polarizing conditions (activated by anti-CD3+
wtAPCs), ~6% of wt CD4+ T cells and ~3% of Sfp1 deleted CD4+ T cells were converted to
IL-9 producing cells, thus representing a ~50% reduction (Fig. 3c), which is consistent with
a role for PU.1 in TH9 induction under certain conditions 6. When OX40 was engaged in the
cultures (activated by anti-CD3+ OX40Ltg APCs), induction of TH9 cells by TGF-β+ IL-4
was essentially the same between wt and Sfp1 deleted CD4+ Tconv, and in either case,
~40% of the CD4+ Tconv were converted to IL-9-producing cells (Fig. 3c). Similar findings
were observed in cultures in which wt and Sfp1 deleted CD4+ T cells were activated with
anti-CD3+ wt APCs and OX86 was added to stimulate OX40 signaling (data not shown).
These findings suggest that PU.1 is dispensable in OX40-mediated induction of TH9 cells.
Wt CD4+ Tconv cells showed no alterations in TGF-β signaling upon activation with or
without OX40 ligation, as assessed by immunoblotting for Smad expression and
phosphorylation (Smad2, 3, 7) (Fig. 3d), which is compatible with the need for TGF-β in
TH9 induction by OX40. Furthermore, expression of IL-2Rα, IL-4Rα, and IL-6Rα as well
as phosphorylation of Stat5, Stat6, and Stat3 were virtually identical between CD4+ Tconv
activated in the presence or absence of OX40 ligation (Fig. 3e). Thus, OX40 seems to
employ a mechanism specifically favoring the induction of TH9 cells.
OX40 activates canonical and non-canonical NF-kB pathways
As a member in the TNFR superfamily, OX40 signals primarily through the activation of
NF-kB, which consists of both the canonical (p50-RelA) and the non-canonical (p52-RelB)
pathways 21. We performed a series of experiments to simultaneously assess the relative
expression of such pathways during T cell activation. We activated wt B6 CD4+ Tconv in
vitro for various times with or without OX40 ligation, followed by extraction of both
cytosolic and nucleus proteins from the activated cells. Induction of key molecules involved
in the activation of both NF-kB pathways was determined by immunoblotting and then
compared. At 36 hrs following T cell activation, p105 (the precursor of p50) was strongly
induced in the cytosol; generation of p50 was similarly induced in CD4+ Tconv activated
with or without OX40 ligation (Fig. 4a). p100 (the precursor of p52) was also strongly
induced in the cytosol, but only under conditions of OX40 ligation was p100 processed to
generate p52 (Fig. 4a). Nuclear accumulation of p50 and RelA (i.e. canonical pathway) was
prominent in CD4+ Tconv activated with either anti-CD3+ wt APCs or anti-CD3+ OX40Ltg
APCs. In contrast, nuclear accumulation of p52 and RelB (i.e. non-canonical pathway) was
observed only in CD4+ Tconv activated in the presence of OX40 ligation (Fig. 4b). These
data suggest that canonical NF-kB (p50-RelA) is a default pathway in activated T cells, and
OX40 ligation additionally activates the non-canonical (p52-RelB) pathway in CD4+ T cells.
Kinetic analyses revealed striking differences in the tempo of canonical and non-canonical
NF-kB activation by OX40. Induction of p105 and p50 in the cytosol by OX40 as well as
their nuclear translocation were rapid and transient, occurring predominantly in the first 24
and 48 hrs after T cell activation (Fig. 4c and Fig. 4d). In contrast, induction of p52 and
RelB by OX40 and their nuclear accumulation were slow but sustained, and 3 days after T
cell activation when p50 and RelA were barely detectable in the nucleus, nuclear expression
of p52 and RelB remained very strong in OX40 ligated T cells (Fig. 4d). These data suggest
that OX40 triggers the activation of both NF-kB pathways; while the canonical pathway is
transient, activation of the non-canonical NF-kB pathway is sustained for a much longer
period of time.
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OX40 requires the non-canonical pathway in TH9 induction
To dissect the relative roles of the canonical versus non-canonical NF-kB pathway in TH9
induction by OX40, we used both loss-of-function and gain-of-function approaches. We
bred dominant negative IkBα-tg (IkBαΔN-tg) mice in which a mutated form of IkBα, which
is resistant to phosphorylation and degradation, is over-expressed as a transgene (driven by
the lck promoter), and therefore, the canonical NF-kB pathway is constitutively repressed 22.
We crossed these mice with Foxp3gfp reporter mice, and flow sorted naive CD4+ Tconv
from such mice. The sorted CD4+ Tconv cells were stimulated with anti-CD3 plus either wt
APC or OX40Ltg APCs under TH9 polarizing conditions, and induction of IL-9 producing
cells was determined by flow cytometry. We confirmed that in IkBαΔN-tg CD4+ T cells, the
canonical pathway (p50-RelA) activation was strongly inhibited, but induction of non-
canonical pathway (p52-RelB) by OX40 ligation and their nuclear translocation were similar
to those in wt CD4+ T cells (Fig. 5a and Fig. 5b). We also confirmed that IkBαΔN-tg T cells
expressed similar levels of OX40 as wt T cells upon activation in vitro; they also
proliferated vigorously upon anti-CD3+ wt APC stimulation and were not apoptotic
(Supplementary Fig. 1). Induction of TH9 cells by OX40 was comparable between wt B6
and IkBαΔN-tg CD4+ T cells, and in either case, ~40% of CD4+ Tconv were converted to
IL-9 producing cells 3 days after the culture (Fig. 5c).
In another set of experiments, we stimulated wt B6 CD4+ Tconv with anti-CD3+ OX40Ltg
APCs under TH9 polarizing conditions, and in these cultures, we added a chemical inhibitor
of canonical NF-kB activation (BAY11-7082), which selectively inhibits IkB
phosphorylation 23, and then assessed TH9 induction at different time points. The doses of
BAY11-7082 used were shown to potently inhibit IkB activation (Fig. 5d). As shown in Fig.
5e, we observed that TH9 induction by OX40 was not affected by the addition of
Bay11-7082 despite strong inhibition of IkB, and ~40% of the CD4+ Tconv became TH9
cells regardless the presence or absence of BAY11-7082. Thus, the canonical NF-kB
pathway appears dispensable in OX40-mediated induction of TH9 cells.
To determine whether the non-canonical pathway plays any roles in TH9 induction, we bred
p52 KO mice in which activation of the non-canonical (p52-RelB) pathway is prevented
because of the lack of p52 generation 24,25. We again sorted CD4+ Tconv from p52 KO
mice, activated them under TH9 polarizing conditions with or without OX40 ligation, and
examined the induction of TH9 cells 3 days later. First of all, we showed that wt B6 and p52
KO CD4+ Tcells are comparable in OX40 expression, proliferation (shown by CFSE
dilutions), and survival (shown by Annexin V staining) upon anti-CD3+ APC activation in
vitro (Supplementary Fig. 2). Approximately 40% of wt CD4+ Tconv were converted to
IL-9 producing cells by TGF-β + IL-4 upon anti-CD3and OX40Ltg APC activation (Fig.
6a). However, p52 KO CD4+ Tconv could not be converted to TH9 cells under identical
culture conditions (Fig. 6a). Thus, the non-canonical p52-RelB pathway plays a key role in
OX40-mediated induction of TH9 cells.
We then used a gain-of-function approach to ascertain the role of the p52-RelB pathway in
TH9 induction. We used a retroviral mediated gene transfer approach to over-express p52-
RelB in wt CD4+ T cells, and then examined the induction of TH9 cells by TGF-β + IL-4
only (without OX40 ligation). When the successfully transduced wt CD4+ Tconv (marked
by the expression of GFP) were cultured under TH9 polarizing conditions, as much as 50%
of the p52-RelB transduced T cells became IL-9 producing cells, whereas the control vector
transduced cells showed minimal IL-9 expression (<5%)under identical culture conditions
(Fig. 6b). In stark contrast, wt CD4+ T cells transduced with p50-RelA did not show marked
induction of IL-9 under the same polarizing conditions (Fig. 6c), thus establishing the
specificity of the p52-RelB pathway in TH9 induction by OX40. These findings complement
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the data obtained using the p52 KO CD4+ T cells, and together they demonstrate an
important role for the p52-RelB pathway in TH9 induction by OX40.
Sequence analysis of the IL-9 promoter region revealed two putative NF-kB binding sites
(Fig. 6d), and chromatin immunoprecipitation (ChIP) showed that p52-RelB could directly
bind to and preferentially enriched at the IL-9 promoter region in TH9 cells polarized under
conditions of OX40 ligation (Fig. 6e). However, ChIP ofp50-RelA in similarly polarized
TH9 cells did not show its selective enrichment in the IL-9 promoter region (Fig. 6f). These
data suggest that p52-RelB may have the potential to directly drive IL-9 transcription. To
test this possibility, we cloned ~1000 bp of the IL-9 promoter region upstream to a
luciferase reporter gene, and transfected this construct into 293T cells. We then determined
the luciferase activities with or without co-transfection of p52-RelB expression constructs,
and found that a significant increase in IL-9 promoter activities could be demonstrated in the
presence of p52-RelB (Fig. 6g).
TRAF6 is critical to the induction of p52-RelB pathway
The requirement for p52-RelB in TH9 induction prompted us to examine how OX40 triggers
the activation of the non-canonical NF-kB pathway. A key step in NF-kB activation by
TNFR superfamily members is the recruitment of TNFR-associated factors (TRAF), the
adaptor molecules required for downstream signaling 26. RT-PCR based array analysis for
all known TRAFs in activated CD4+ Tconv (48 hrs after T cell activation) showed that
TRAF6 mRNA was preferentially induced upon OX40 ligation, while expression of other
TRAFs was not markedly different with or without OX40 ligation(Fig. 7a). The increased
expression of TRAF6 protein in CD4+ Tconv following OX40 stimulation was further
confirmed by immunoblotting, and the difference in TRAF6 expression by activated CD4+ T
cells with or without OX40 ligation was striking (Fig. 7b).
Besides being an adaptor molecule, TRAF6 also functions as an ubiquitin ligase 27. The
exact role of TRAF6 in regulating OX40 signaling in T cells has not been examined. We
then crossed Traf6 floxed mice with Cd4-Cre mice to specifically delete Traf6 in CD4+ T
cells (Traf6f/fCd4cre) 28. We sorted CD4+ Tconv from wt B6 and Traf6f/fCd4cre mice,
activated them with anti-CD3 plus either wt APCs or OX40Ltg APCs, and then examined
the activation of NF-kB pathways by immunoblotting. OX40 ligation on activated CD4+ T
cells triggered strong activation of NF-kB-inducing kinase (NIK) under either neutral or TH9
polarizing conditions, which corroborates a recent report in a different model (Fig. 7c) 29.
NIK activation mediates the processing of p100 to p52, and this is further correlated very
well with prominent nuclear accumulation of p52 and RelB (Fig. 7c and Fig. 7d). Deletion
of Traf6 in CD4+ Tconv prevented the induction of NIK by OX40 and the subsequent
generation of p52 from p100. The defective p52 generation in Traf6deleted CD4+ T cells
inhibited the nuclear accumulation of p52-RelB, thus blocking activation of the non-
canonical NF-kB pathway (Fig. 7c and Fig. 7d). TRAF6 therefore plays a pivotal role in the
induction of NIK upon OX40 ligation, and the subsequent activation of the non-canonical
NF-kB pathway.
OX40 fails to convert Traf6f/fCd4cre cells to TH9 cells
To determine the role of TRAF6 in TH9 induction, we again flow sorted CD4+ Tconv from
wt B6 and Traf6f/fCd4cre mice, stimulated them with anti-CD3 plus either wt or OX40Ltg
APCs under TH9 polarizing conditions, and then examined the induction of TH9 cells at
different time points. Wt B6 and cells showed similar expression of OX40 upon activation
(Fig. 8a); they also showed comparable proliferation (CFSE dilutions) and survival
(Annexin V staining) upon anti-CD3+ APC stimulation in vitro (Fig. 8b). OX40 ligation
converted a large fraction (~40%)of wt CD4+ Tconv to TH9 cells (Fig. 8c). In sharp contrast,
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OX40 ligation failed to convert Traf6f/fCd4cre CD4+ T cells to TH9 cells (<3%). This
inhibition of TH9 induction is very similar to that observed in p52 KO cells (Fig. 6a). In both
p52 KO and Traf6 deleted CD4+ T cells, PU.1, IRF4, and Gata3mRNA and protein
expression did not show marked differences upon T cell activation when compared to those
in wt B6 CD4+ T cells (Supplementary Fig 3).
To ascertain that the lack ofTH9 induction in Traf6f/fCd4creCD4+ T cells is truly due to the
impaired p52-RelB activation, we transduced Traf6f/fCd4cre CD4+ T cells with retroviral
vectors encoding RelB and p52, and the successfully transduced T cells were marked by the
expression of GFP. Such GFP positive Traf6f/fCd4cre CD4+ T cells were further cultured
under TH9 polarizing conditions for 3 days (without OX40 ligation), and induction of IL-9
producing cells within the GFP positive population was determined by flow cytometry.
Control vector transduced Traf6f/fCd4cre T cells did not show detectable levels of IL-9,
however Traf6f/fCd4cre T cells transduced with p52-RelB readily became IL-9 producing
cells under TH9 polarizing conditions (Fig. 8d) Conversely, CD4+ T cells transduced with
p50-RelA failed to produce IL-9 under identical culture conditions (Fig. 8e), further
demonstrating the importance of the p52-RelB pathway in TH9 induction. Together, these
data demonstrate an indispensable role for TRAF6 and p52-RelB in OX40-mediated
induction of TH9 cells.
OX40 triggers TH9-mediated airway inflammation in vivo
To examine the role of the OX40-TH9 axis in vivo, we first compared wt B6 and OX40L-tg
mice for signs of tissue inflammation in vivo by histopathology. Consistent with previous
reports 16, OX40L-tg mice developed signs of extensive autoimmune diseases (data not
shown). Histologically, the lung was prominently involved, with signs of severe interstitial
and airway inflammation 19. Masson’s trichrome (MTC) staining showed epithelial
hyperplasia and sub-mucosal fibrosis, and PAS&AB staining revealed hyper-proliferation of
mucin-producing cells in the airway epithelium in OX40L-tg mice (Fig. 9a). Quantitative
assessment showed that as much as 30% of airway epithelial cells were mucin-producing
cells in OX40L-tgmice, and this is reminiscent of that seen in IL-9 transgenic mice in the
lung airways 30. Indeed, Real-Time PCR analysis for a panel of pro-inflammatory cytokines
in the lung tissues revealed high expression of IL-9and IL-13in OX40L-tg, but not in wt,
mice (Fig. 9b). This was further confirmed by flow cytometry, which identified an expanded
population of CD4+CD44hi T effector/memory cells that spontaneously produce IL-9 in situ
(Fig. 9c).
In a different set of experiments, we injected an agonist anti-OX40 mAb (OX86) into wt and
Il9 KO mice, and then assessed changes in the lungs. A brief treatment with OX86 induced
prominent bronchial epithelial hyperplasia and hyper-proliferation of mucin-producing cells
in the wild type mice, as shown by PAS&AB staining (Fig. 9d). In contrast, these changes
were completely absent in similarly treated Il-9 KO mice (Fig. 9d). Furthermore, in a
standard asthma model involving OVA sensitization and re-challenge, hyper-proliferation of
mucin-producing cells was similarly induced in wt B6 mice, but not in Ox40 KO mice (Fig.
9e). ELISA revealed markedly reduced IL-9 in the bronchial alveolar lavage (BAL) in OVA
challenged Ox40 KO mice (0.08 ± 0.02 ng/ml, n=3) as compared to that in wt B6 mice (3.83
± 0.43 ng/ml, n=3 (p<0.05). Additionally, TH9 cells derived from OT-II cells under
conditions of OX40 ligation induced marked proliferation of mucin-producing cells upon
adoptive transferring to Rag1−/− mice, and this effect was markedly inhibited by neutralizing
IL-9 (Supplementary Fig. 4). Together, these data demonstrate a direct role of OX40 in TH9
induction and airway inflammation in vivo.
Xiao et al. Page 7
Nat Immunol. Author manuscript; available in PMC 2013 October 23.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Discussion
The recently identified IL-9 producing ‘TH9 cells’ are a new addition to the family of TH
subsets 31,32. However, the precise identity of TH9 cells and the exact mechanisms that
regulate TH9 induction remain somewhat contested 18. Here, we demonstrate a significant
mechanism of TH9 cell induction. First, the costimulatory molecule OX40 is unexpectedly
potent in favoring TH9 induction. OX40 ligation together with TGF-β and IL-4 can covert as
much as 80% of CD4+ Tconv to TH9 cells, demonstrating a remarkable potency of this
costimulatory pathway in the induction of TH9 cells. Second, we identified a new molecular
mechanism by which OX40 favors TH9 cells. OX40 ligation activates the ubiquitin ligase
TRAF6, which mediates the activation of NIK; NIK activation results in the processing of
p100 to generate the p52subunit, and together with RelB, they form the transcriptionally
active p52-RelB complex. This non-canonical NF-kB pathway is essential forTH9 induction
by OX40. Third, TH9 cells induced by OX40 appear to be distinct from other published TH9
cells in that they do not express other cytokines 31–33, suggesting that TH9 cells generated
under conditions of OX40 costimulation may represent authentic TH9 cells. This new
finding further solidifies TH9 cells as a distinct TH subset and may facilitate further
mechanistic studies of TH9 cells as well as the role of TH9 cells in various diseases. Finally,
we provide in vivo evidence that OX40 is critically important in driving hyper-proliferation
of mucin-producing cells in the airway epithelium, demonstrating the in vivo importance of
TH9 cells.
In most studies, TH9 cells are induced most effectively by TGF-β and IL-4 34, but cells
committed to IL-9 production are often at very low levels (<10%), especially under
conditions in which APCs are involved in activation of CD4+ T cells 35. This low frequency
of TH9 cells makes functional and mechanistic studies of such cells difficult, and also casts
considerable uncertainty on whether TH9 cells are truly a separate lineage. In fact, TH9 cells
induced by TGF-β and IL-4 co-express other cytokines including IL-4 or IL-10 31,32. The
recent findings that TH17 cells, TREGS, or even innate immune cells can also express IL-9
suggest that IL-9 may be a shared cytokine among multiple cellular subsets 33,36,37. This is a
particular concern considering that the transcription factors PU.1 and IRF4, though closely
associated with TH9, are not specific to TH9 cells, and they are also involved in the
induction of other cell types including TH2 cells 38. In the current studies, we demonstrate
that ligation of OX40, together with TGF-β and IL-4, induce high levels of TH9 cells, and
such TH9 cells don’t express cytokines commonly seen in TH9 cells induced under other
conditions 18. Previous studies have shown that OX40 potently shuts down the induction of
IL-10 in activated T cells 39. These data, together with our findings that OX40 also turns off
the induction of TH17 cells and iTregs, suggest that TH9 cells induced under conditions of
OX40 stimulation are different cells from those induced without OX40 ligation. Those
induced by TGF-β and IL-4, possibly through the action of PU.1 and IRF4, may be meta
stable or intermediaries, as they express features of other TH subsets, whereas additional
OX40 signaling may promote further differentiation of TH9 cells by turning off the
expression of other cytokines. However, whether OX40 signaling transiently modulates IL-9
expression while suppressing other cytokines or stably re-programs the cytokine locus in
differentiated TH9 cells remains to be defined. This is a significant area that deserves further
investigation.
Despite thepotency of OX40 in TH9 induction, OX40 does not seem to operate through the
well-described TH9-associated transcription factors PU.1 and IRF4 5,6. Instead, OX40
ligation triggers sustained activation of the non-canonical NF-kB pathway in CD4+ T cells
that is critically involved in the induction of TH9 cells. OX40 maybe unique in this regard,
because stimulation via GITR, another member in the TNFR superfamily that is also
expressed on activated CD4+ T cells 8, fails to support TH9 induction (our unpublished
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observation). Thus, there appears to be a certain degree of selectivity among TNFR
superfamily members in the activation of the non-canonical NF-kB pathway, but the exact
mechanisms as to why OX40 preferentially engages the p52-RelB pathway remain to be
clearly defined. The promoter region of Il9 contains multiple NF-kB binding sites, as does
the conserved non-coding region of Il9 18. Indeed, p52-RelB, but not p50-RelA, can directly
bind to the Il9 promoter region and triggers IL-9 transcriptional activity under TH9
polarizing conditions. The involvement of the non-canonical p52-RelB pathway does not
exclude the importance of other factors in TH9 induction. In fact, TGF-β and IL-4 are
mandatory for optimal TH9 induction by OX40, since in the absence of TGF-β and IL-4,
OX40 instead promotes a strong TH1 response 9. Thus, the non-canonical p52-RelB pathway
most likely collaborates with other factors downstream of such cytokine signaling that
collectively coordinate the induction of TH9 cells, although the factors activated by the TH9
polarizing cytokines are not known and are not addressed in this study. Some emerging data
suggest the possibility of T-bet inhibition by such cytokines 40. Nonetheless, the striking
effect of OX40 in TH9 induction suggests that the p52-RelB pathway mostly likely
predominates this response, and other factors downstream of the polarizing cytokines may
simply create a permissive environment for p52-RelB to act during TH9 differentiation. In
fact, two recent studies demonstrating the involvement of NF-kB in IL-9 expression in
different settings and different cell types seem to support this notion 41,42. In addition, the
effect of OX40 ligation also involves the repression of TH17 cells and iTregs, but the
mechanisms responsible for such an effect await further identification. Studies in this area
may uncover additional insights on the role of OX40 in the control of T cell responses.
In summary, our study identified OX40 as a powerful inducer of TH9 cells and uncovered a
previously unknown mechanism triggered by OX40 in selective induction of TH9 cells. TH9
cells induced by OX40 are different in that they express remarkably high levels of IL-9
without other TH2 or TH17 cytokines. Such TH9 cells are stable, can be induced in vivo and
exhibit a potent effect on airway epithelial cells and mucin-producing cells. These new
findings may have important clinical implications 43.
ONLINE METHODS
Animals
OT-II and Cd4-Cre mice were purchased from The Jackson Laboratory (Bar Harbor, ME).
Tnfrsf4 (OX40) KO, Tnfsf4 (OX40L-tg), p52 KO, Traf6 floxed (Traf6f/f), and Foxp3gfp
reporter mice have been described previously 4,25,28,44,45. Some strains were crossed with
the Foxp3gfp mice to genetically mark Foxp3+ TREGS for cell sorting. Il9 KO mice were
provided by A. McKenzie (MRC Laboratory of Molecular Biology); IkBαΔN-tg mice were
obtained from M. Alegre (University of Chicago). Sfp1 (PU.1) floxed mice (Sfp1 f/f) were
provided by D. Tenen (Harvard Medical School). Animal use and care conformed to the
guidelines established by the Animal Care Committee at Harvard Medical School in Boston.
Polarization of naïve CD4+ T Cells in vitro
Naive CD4+ T cells (CD62L+CD44−Foxp3−) were prepared by flow sorting; the sorted cells
(1×105 cells/well) were activated with anti-CD3 (2ug/ml; clone 2C11, eBioscience) plus
equal numbers of syngeneic APCs in 96 well tissue culture plates (Sigma-Aldrich). In some
experiments, OT-II CD4+ T cells were stimulated with OVA323–339 (1 μg/ml) presented by
syngeneic APCs. APCs were prepared by depleting T cells from total spleen cells with anti-
CD3-PE and anti-PE microbeads (Miltenyi Biotec), followed by a brief treatment with
mitomycin C (50 μg/ml, Sigma-Aldrich) before each experiment. Induction of iTregs, TH17
cells, and TH9 cells was performed as previously reported 4,32. Briefly, cells were activated
in the presence of 3ng/ml hTGF-β1 and 10ng/ml IL-2for iTreg induction, and for TH17
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polarization, 3ng/ml hTGF-β1, 10ng/ml IL-6 were used. Furthermore, 3ng/ml hTGF-β1 and
10ng/ml IL-4 were used to polarize CD4+ T cells to TH9 cells. All recombinant cytokines
were purchased from R&D systems. CD4+ T cells cultured under different polarizing
conditions (for 1 to 4 days) were harvested and cell polarization assessed by intracellular
staining and quantitative Real-Time PCR. Cytokines in the culture supernatants was
determined by ELISA.
Intracellular staining
For cytokine staining, CD4+ T cells activated under different polarizing conditions were re-
stimulated with PMA (50 ng/ml) and ionomycin (550 ng/ml; Sigma-Aldrich) for 4 hours in
the presence of Golgi Stop (BD PharMingen). Cells were fixed and permeabilized with
Cytofix/Cytoperm solution (BD PharMingen) and stained with fluorochrome-conjugated
anti-IL-9 (RM9A4, BioLegend), anti-IL-10 (JES5-16E3; BD PharMingen), anti-IL-13
(JES10-5A2; BD Pharmingen), anti-IL-4 (11B11; BD Pharmingen), anti-IL-5 (TRFk5;
eBioscience), anti-IFN-γ (XMG1.2; BioLegend), anti-IL-17F (9D3.1C8; BioLegend) and
anti-IL-17A (TC11; BioLegend). In some experiments, iTregs was determined by the
expression of GFP; Stat3, Stat5, and Stat6 in activated CD4+ T cells was assessed by
intracellular staining with phospho-specific mAbs (BD PharMingen). Antibodies against
PU.1 (9G7; Cell Signaling Technology), IRF4 (3E4; eBioscience), and Gata3 (L50-823; BD
PharMingen) were used to determine their expression in naïve and activated CD4+ T cells
according to manufacturer’s instructions. All samples were acquired using LSRII flow
cytometer (Beckton Dickinson) and data analysis was performed using Flowjo 7.6 software
(Tree Star) 46.
Quantitative PCR and ELISA
Cellular RNA was extracted using the RNeasy mini kit (Qiagen) and reverse transcribed into
cDNA using the ABI PRISM TaqMan reverse transcription method. Expression of genes of
interest and of GAPDH control was assessed in simplex RT-PCR reactions with FAM and
VIC probes (Applied BioSystems). All primer and probe sets were purchased from Applied
BioSystems. Transcript levels of target genes were calculated according to the 2−ddCT
method as described by the manufacturer (ABI PRISM 7700 user bulletin; Applied
BioSystems) and expressed as arbitrary units as previously reported 10. IL-9 levels in culture
supernatants were measured with the ELISA kit (eBioscience) according to the
manufacturer’s instructions.
Immunoblotting
Protein extracts were resolved by SDS-PAGE, transferred onto an immunobilon membrane,
and blotted with specific antibodies. The following antibodies were used for
immunoblotting: anti-β-actin (Sigma-Aldrich), anti-p105/p50, and anti-RelA (Abcam), anti-
p100/p52, anti-RelB, anti-NIK, anti-HDAC1, anti-IkB, anti-Smads and other secondary
antibodies (Cell Signaling Technology). Expression of target molecules was revealed by
chemoilluminant method as previously reported 47.
Chromatin immunoprecipitation (ChIP)
Chromatins were extracted from naive CD4+Foxp3− T cells polarized under various
conditions for 48 to 72 hrs (15×106 cells) after fixation with formaldehyde.
Immunoprecipitation of chromatin was performed with anti-RelB, anti-RelA, and isotype
control antibody (Abcam) using EZ ChIP kit (Millipore) according to the manufacturer’s
instructions. Immunoprecipitated DNA was reverse cross-linked, extracted with phenol/
chloroform, and further precipitated with ethanol. ChIP DNA was then analyzed by real-
time PCR using the following primer sets (Rel B: 5′-
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CTTTTCCTTTAGTATTTCAGAACCCGA-3′ and 5′-
TCAGTCTACCAGCATCTTCCAGT-3′; RelA: 5′
AATGAGTGAAAGGCAAGTCTTGCTTT-3′ and 5′
TCGGGTTCTGAAATACTAAAGGAAAAG-3′). The data are presented as the relative
binding based on normalization to input DNA, as previously reported 5.
Promoter luciferase assay
A luciferase reporter assay was performed as previously reported 48. Briefly, the IL-9
promoter region, 1kb in size upstream of the transcription start site, was cloned into pGL3
luciferase reporter plasmid (Promega). HEK293 T cells were transfected with the reporter
constructs, together with expression plasmids carrying murine p50, p52, RelB, RelA cDNA
using Lipofectamine 2000 method (Invitrogen). After 48 h, the luciferase activities were
analyzed using the dual-luciferase reporter assay system (Promega). Co-transfection with the
Renilla-luciferase expression vector pRL-TK was performed in all reporter assays. For all
samples, the assays were repeated for at least three times and the data were normalized for
transfection efficiency by dividing firefly luciferase activity by that of the Renilla luciferase.
Retroviral mediated gene expression
The cDNA fragments encoding RelA, p50, RelB, and p52 were amplified by PCR and
further cloned into pMYs-IRES-EGFP retroviral vector (Cell Biolabs). The retrovirus
particles were prepared by transfecting the packaging Plat-E cells based on the
manufacturer’s recommendations. To transduce T cells, naive CD4+ T cells were first
activated with the Dynabeads Mouse CD3/CD28 T Cell Expander (Invitrogen) for 24 hrs,
followed by incubating with freshly prepared retroviral particles by centrifugation at 780g
and 32°C in the presence of 10μg/ml polybrene (Sigma-Aldrich) for 2hrs. After the
centrifugation, cells were further cultured at 32°C for 6 hrs, followed by culturing the
transduced T cells under various polarizing conditions for additional 3 days in complete
1640 medium at 37°C. Polarization of CD4+ T cells to TH9 cells was assessed by
intracellular cytokine staining as described above.
Tissue histopathology
Tissue samples were prepared from animals, embedded in paraffin, sectioned and stained
with hematoxylin and eosin (H&E). Periodic acid schiff/alcian blue (PAS&AB) and
Masson’s trichrome staining (MTC) were also performed to assess mucin-producing cells
and tissue damage 30. To quantify tissue histopathology, peri-bronchial and peri-vascular
cellular infiltration as well as fibrosis were graded using a semi-quantitative score system (0
to 4 and 0 denotes no inflammation) as previously reported 5. For each slide, five randomly
chosen areas were scored. For quantifying PAS/AB staining, mucus production was assessed
by determining the percentage of epithelial cells that stained strongly positive 49. Individual
slides were examined independently and representative sections were shown.
Induction of lung inflammation
Groups of WTB6 and OX40 KO mice (8 weeks of age) were sensitized i.p. with 50 μg OVA
dissolved in aluminum hydroxide (50mg in 100ml alum, Sigma). Mice were challenged with
5% OVA aerosol 4 weeks later for 2 days (30 min each), before analyses. In other
experiments, OT-II cells were polarized to TH9 cells by TGF-β and IL-4 upon activation
with OVA and OX40L-tg APCs for 4 days (IL-9+ cells >80%). TH9 cells (1×106) were
injected into syngeneic Rag1−/− hosts via the tail vein. OT-II cells activated without the
polarizing cytokines were used as controls. The host mice were challenged with aerosolized
OVA (5% in saline) via the airway 30 min daily for 2 days. Groups of mice were also
treated with a neutralizing anti-IL-9 (150 μg, clone 222622, R&D) or control IgG before
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OVA challenge. Mice were killed 1 day after the OVA challenge; bronchial alveolar lavage
(BAL) was performed, and cells in BAL fluid were determined using cytospin and modified
Wright-Giemsa staining. Tissue samples were prepared and stained with H&E, PAS&AB
for analysis. Each group included 5 mice.
Statistical analysis
The Mann-Whitney test was used for histology score analysis. Other measurements were
performed using unpaired two-tailed Student’s t test. A p value < 0.05 was considered
significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Role of OX40 signaling in polarization of naive CD4+ T cells in vitro
Naive CD4+ T cells sorted from WTB6, Ox40 KO, and OT-II Foxp3gfp reporter mice were
cultured under iTreg, TH17, or TH9 polarizing conditions in vitro with or without engaging
OX40 signaling, and induction of iTregs, TH17, and TH9 cells on day 3 was shown. (a)
Induction of iTregs under polyclonal (anti-CD3) and antigen-specific settings (OVA323–339)
in which WT APCs (WT) and OX40L-tg APCs (OX40L-TG) were used to activateCD4+ T
cells. CD4+ T cells cultured without polarizing cytokines were included as controls (Ctrl).
Numbers in quadrants denote the relative percentage of cells. The plot shown is a
representative plot of 5 independent experiments. (b)Induction of TH17 cells under
polyclonal and antigen-specific settings as described above. Numbers in quadrants denote
the percentage of cells. The plot shown is a representative plot of 5 independent
experiments. (c) Induction of TH9 cells from naïve B6 CD4+ T cells stimulated with anti-
CD3+ WT APCs (WT) or OX40L-tg APCs (OX40L-TG). The panel on the right is a
summary of all experiments performed and the dots denote individual experiments (n=10).
(d)Naive CD4+ T cells were activated with anti-CD3plus WTAPCs with or without an
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agonist anti-OX40 mAb (OX86), and induction of TH9 cells was shown. The panel on the
right is a summary of individual experiments (n=10). (e) Naïve B6 and Ox40 KO CD4+ T
cells were activated with anti-CD3and APCs under TH9-polarizing conditions, and induction
of IL-9 producing cells was shown. The panel on the rights is a summary of all experiments
(n=10). * p <0.05.
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Figure 2. Role of OX40 ligation in polarization of OT-II T cell subsets in vitro
Naive OT-II CD4+ cells were stimulated with the cognate OVA antigen presented by either
wt APCs (WT) or OX40L-tg APCs (OX40L-TG), with or without the TH9 polarizing
cytokines, and induction of TH9 cells was assessed by flow cytometry, quantitative PCR,
and ELISA. (a) Conversion of naive OT-II cells to TH9 cells with or without OX40 ligation
on day 3; the data shown is a representative flow cytometryplot. The panel on the right
represents all experiments, and dots denote individual experiments (n=10). (b) OT-II cells
were polarized under TH9 conditions for 3 days, and IL-9 expression was assessed by co-
staining for other cytokines. Data shown are representative plots of 4 individual
experiments. (c) OT-II cells were activated with OVA presented by WTAPCs (WT) and
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OX40Ltg APCs (OX40L-TG) for various times, and IL-9 expression was quantified by
Real-Time PCR. Data shown are mean ±SEM of 3 experiments. (d) OT-II cells were
activated with OVA plus WTAPCs (WT) or OX40Ltg APCs (OX40L-TG) for various
times, and production of IL-9 in the culture supernatants was assessed by ELISA. Data
shown are mean ± SEM of 3experiments.
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Figure 3. Role of PU.1 and cytokine signaling in OX40-mediated induction of TH9 cells
(a) Naive CD4+ T cells sorted from wt B6 and PU.1 (Sfp1) deleted mice were activated with
anti-CD3and APCs for 3 days and OX40 expression was assessed by flow cytometry and
shown. (b) Proliferation and survival of WT-B6 and Sfp1 KOCD4+ T cells as determined by
CFSE dilutions and Annexin V staining 3 days after activation with anti-CD3and WT APC.
(c) Naive CD4+ T cells from WTB6 and Sfp1 KO mice were activated with anti-CD3 plus
wt APCs (WT) or OX40Ltg APCs (OX40L-TG) under TH9-polarizing conditions for 3
days, and induction of TH9 cells was shown. Numbers in quadrants indicate the percentage
of in each section, and the panel on the right summaries all experiments with dots denoting
individual experiments. (d) Immunoblotting analysis of Smad2, Smad3, Smad7 in CD4+
Tconv activated with anti-CD3 plus WT APCs (WT) or OX40Ltg APCs (OX40L-TG) with
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or without additional TGF-β. The plot shown represents 1 of 4 experiments 24 hrs after T
cell activation. (e) Expression of IL-2Rα, IL-4Rα, and IL-6Rα as well as activation of Stat5,
Stat6, and Stat3, respectively, in CD4+ Tconv activated with anti-CD3 plus either WTAPCs
(WT) or OX40Ltg APCs (OX40L-TG). The analysis was done 24 hrs after T cell activation
and unstimulated naive T cell were included in the analysis as controls. Data are
representative of 1 of 3 independent experiments.
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Figure 4. Role of OX40 ligation in the activation of both canonical and non-canonical NF-kB
pathways
Naive CD4+ Tconv were activated with anti-CD3plus WT APCs (WT) or OX40Ltg APCs
(OX40L-TG), and at different time points, cytosolic (Cyt) and nucleus (Nuc) proteins were
extracted and examined for NF-kB activation by immunoblotting. Naive unstimulated CD4+
T cells were used as controls. (a, b) Induction of the canonical (p50-RelA) and non-
canonical (p52-RelB) NF-kB pathways in the cytosol (a) and nucleus (b) 36 hrs after T cell
activation is shown. (c, d) Time-dependent assessment of p50-RelA and p52-RelB pathways
(from 1 hr to 72 hrs following T cell activation) in the cytosol (Cyt) and nucleus (Nuc). β-
actin and HDAC1 (histone deacetylase 1) were used as loading controls. Data shown are
representative of 1 of 3 independent experiments.
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Figure 5. Role of the canonical NF-kB pathway in OX40-mediated induction of TH9 cells
(a, b) WT-B6 and IkBαΔN-TGCD4+ cells were activated for 24 hrs with anti-CD3 plus WT
APCs (WT) or OX40Ltg APCs (OX40L-TG), and induction of p50-RelA and p52-RelB in
the cytosol (Cyt) and nucleus (Nuc) was assessed by immunoblotting. The plot shown is
representative data of 1 of 3 experiments. (c)Naive WT-B6 and IkBαΔN-TGCD4+ T cells
were activated with anti-CD3plus WT APCs (WT) or OX40Ltg APCs (OX40L-TG) under
TH9 polarizing conditions, and the plots shown are IL-9-producing cells on day 3, as
determined by flow cytometry. Numbers in quadrants indicate relative percentage of cells in
each section. The panel on the right is a summaryofTH9 cells and the dots represent
individual experiments (n=10). (d) Phosphorylation of IkB in CD4+ T cells with or without
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the addition of different doses of an IkBα inhibitor, BAY11-7082, two days after
stimulation. (e) WTB6 CD4+ T cells were stimulated with anti-CD3and OX40Ltg APCs
under TH9 polarizing conditions, and BAY11-7082 was added as indicated. Induction of
IL-9 producing cells was examined 3 days later. Data are representative of 1 of 3
independent experiments.
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Figure 6. Role of the non-canonical NF-kB pathway in OX40-mediated induction of TH9 cells
(a) WT-B6 and p52-KO CD4+ T cells were activated with anti-CD3 plus WT APCs (WT) or
OX40Ltg APCs (OX40L-TG) under TH9 polarizing conditions for 3 days, and induction
TH9cells was shown. The panel on the right is the percentage of TH9 cells among naïve
CD4+ T cells and the dots denote individual experiments (n=10). (b) Retroviral transduced
WTCD4+ Tconv expressing RelB and p52 were cultured with or without TH9 polarizing
cytokines for 3 days, and induction of TH9 cells was shown. The panel on the right depicts
the results of all experiments (n=10). (c) WT-B6 CD4+ T cells were transduced with
retroviral vectors encoding p50 and RelA, and IL-9 expression by the transduced T cells
under TH9-polarizing conditions on day 3 was shown. The right panel depicts the results of
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all experiments (n=10). (d) Putative NF-kB binding sites in the IL-9 promoter region. The
red color depicts the, and the TATA box is shown in bold font. (e) WTCD4+ T cells were
activated with anti-CD3 plus either WT APCs (WT) or OX40Ltg APCs (OX40L-TG) under
either neutral (Ctrl) or TH9 inducing conditions (TGF-β + IL-4), and enrichment of RelB at
the IL-9 promoter region was determined by ChIP and shown. Data shown are
representative of 1 of 3 independent experiments. (f) WTCD4+ T cells were cultured under
either neutral or TH9 polarizing conditions, and ChIP of RelA binding to the IL-9 promoter
region was shown. One of 3independent experiments is shown. (g) 293T cells were
transfected with IL-9 promoter-luciferase construct with or without expression vectors
encoding full-length RelB and p52. The promoter activity is presented as fold increase over
cells transfected with the empty vector alone. Data are 1 of 3 independent experiments
(mean ± SEM), * p<0.05.
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Figure 7. Analysis of TRAF6 in OX40 triggered activation of non-canonical NF-kB pathway
(a) Naive WTCD4+ T cells were stimulated with anti-CD3 plus either WTAPCs (WT) or
OX40Ltg APCs (OX40L-TG) for 48 hrs, and expression of Traf1 to Traf7 was quantitated
by real-time PCR. (b) Immunoblotting showing strikingly different TRAF6 expression in
activated CD4+ T cells with or without OX40 ligation at various time points. (c, d) Naive
WT-B6and TRAF6 deleted (Traf6f/fCd4cre) CD4+ T cells (T6f/f) were activated with wt
APCs (WT) or OX40Ltg APCs (OX40L-TG) under either neutral or TH9-polarzing
conditions for 48 hrs. Cytosolic (Cyt) and nucleus (Nuc) proteins were extracted and
expression of p105, p100, RelA, RelB, p52, p50, and NIK was assessed simultaneously by
immunoblotting and compared. Data were representative of 3 independent experiments. *
p<0.05.
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Figure 8. Conditional deletion of Traf6 in CD4+ T cells prevents TH9 induction by OX40
(a) OX40 expression by activated WTB6 (Act WT) and TRAF6-deleted CD4+ T cells (Act
T6f/f) 3 days after activation. One of 3 experiments is shown. (b) Proliferation and survival
of wt B6 and Traf6-deleted CD4+ T cells (T6f/f) 3days after anti-CD3and APC stimulation.
One of 3 experiments is shown. (c) Naive WT-B6and Traf6f/fCd4cre CD4+ T cells (T6f/f)
were activated with anti-CD3plus either WT APCs (WT) or OX40Ltg APCs (OX40L-TG)
under TH9 polarizing conditions for 3 days, and induction of IL-9 producing cells was
determined by flow cytometry. The panel on the right shows the summary of TH9 cell
frequency induced in all experiments; the dots denote individual experiments (n=10). (d)
Activated CD4+ cells from Traf6f/fCd4cre mice were transduced with retroviral vectors
encoding p52 and RelB or control vectors. The transduced T cells were cultured under TH9
polarizing conditions (without OX40 ligation) for 3 days, and induction of IL-9 producing
cells among the successfully transduced T cells (marked by GFP expression) was
determined by flow cytometry. The right panel indicates the relative frequency of TH9 cells
induced in all experiments (n=10). (e) Activated CD4+ T cells from Traf6 deleted mice were
transduced with retroviral vectors encoding p50 and RelA, and further cultured under TH9
polarizing conditions for 3 days. IL-9 expression was assessed by flow cytometry and
shown. The right panel shows the summary of all experiments (n=10). * p<0.05.
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Figure 9. The in vivo effect ofOX40 in TH9 induction and airway inflammation
(a) Tissue pathology in the lungs of wt B6 and OX40Ltg mice (20 wks of age), as assessed
by H&E, MTC, and PAS&AB staining. The pictures shown are representative of 5 animals
in each group. The arrows denote mucin-producing cells in the airway epithelium; the
histograms show quantitative histology scores and % of PAS&AB+ cells among airway
epithelial cells. Magnifications, 400X. (b) Quantitative RT-PCR analysis of a panel of
cytokines in the lung samples from wt B6 and OX40Ltg mice. Data shown are mean ±SEM
of 3 animals. (c) Tissue infiltrating cells in the lungs of WTB6 and OX40Ltg mice were
isolated and examined for IL-9 expression by flow cytometry. Cells were labeled with anti-
CD4 and anti-CD44, and IL-9 expression in the CD4+ population was shown. One of 10
experiments is shown. (d) WT and IL-9-KO mice were briefly treated with an agonist anti-
OX40 mAb, as described in the Methods section, and changes in the lung airways were
assessed by H&E (100X) and PAS&AB staining (400X). The arrows denote mucin-
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producing cells in the airway epithelium. The pictures shown are representative of 5 animals
in each group. The histogram shows the % of mucin-producing cells relative to airway
epithelial cells. (e) WTB6 mice and OX40-KO mice were firstly sensitized and then re-
challenged with OVA, and the lung tissue pathology as well as airway inflammation were
shown. The arrows show mucing-producing cells, and the histograms depict quantitative
histology scores and mucin-producing cells. Each group included 3 animals. * p < 0.05.
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